Warfarin and Aspirin Versus Aspirin Alone in Patients with Acute Myocardial Infarction: A Pilot Study

Angiology

Volumn 55, Issue 1, 2004, Pages 17-20

  Zibaeenezhad, M J ^a,b   Mowla, A ^a   Sorbi, M H ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; HEART INFARCTION; HISTORY OF MEDICINE; HOSPITALIZATION; HUMAN; IATROGENIC DISEASE; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PILOT STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; SHOCK; TREATMENT OUTCOME;

EID: 0347093530     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970405500103     Document Type: Article

References (13)

1. American Heart Association: Heart and Stroke Facts: 2000 Statistical Supplement. Dallas: American Heart Association, 2000.
2. Braunwald F, Fauci A, Kasper D, et al: Acute myocardial infarction. In: Harrison's Principles of Internal Medicine, ed. 15, ed. by Antman EM, et al. New York: McGraw-Hill, 2001, pp 1386-1399.
3. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS) Investigators. Lancet 350:389-396, 1997.
4. Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. Br Med J 308:81-106, 1994.
5. Van Es RF, Jonker JJ, Verheugt FW, et al: Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): A randomized controlled trial. Lancet 360:109-113, 2002.
6. Fiore LD, Ezekowitz MD, Brophy MT, et al: Clinical trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: Primary results of the CHAMP study. Circulation 105:557-563, 2002.
7. Huynh T, Theroux P, Bogaty P, et al: Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation 103:3069-3074, 2001.
8. Braunwald F, Zipes D, Libby P: Hemostasis, thrombosis, fibrinolysis and cardiovascular disease. In: Heart Disease, ed. 5, ed. by Fuster V, Verstrate M. Philadelphia: WB Saunders, 1997, p 1827.
9. Smith P, Arnesen H, Holme I, et al: The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 323:147-152, 1990.
10. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. The ASPECT Research Group. Lancet 343:499-503, 1994.
11. Goodman SG, Langer A, Durica SS, et al: Safety and anticoagulation effect of low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction Study (CARS) Group. Am J Cardiol 74:657-661, 1994.
12. O'Connor CM, Gattis WA, Hellkamp AS, et al: Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction study (CARS). Am J Cardiol 88:541-546, 2001.
13. Brouwer MA, van den Bergh PJ, Aengevaeran WR, et al: Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: Results of the antithrombotics in the prevention of reocclusion in coronary thrombolysis (APRICOT)-2 trial. Circulation 106:659-665, 2002.